Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mead infant formula recall

This article was originally published in The Tan Sheet

Executive Summary

BMS subsidiary initiates voluntary recall of 505 cases of EnfaCare LIPIL 12.9 oz. powdered formula due to contamination with Enterobacter sakazakii bacteria, FDA announces Jan. 9. Cases and cans are coded BME01, with an expiration date of Jan. 1, 2004, and were shipped to hospitals, retail stores and Women, Infant & Children clinics nationwide, firm says. Mead Johnson notes it has not received adverse event reports associated with the batch; E. sakazakii has been linked to rare cases of sepsis, meningitis, necrotizing enterocolitis in newborn infants. Bacteria has posed problems for several powdered infant formula manufacturers in the past; both Mead and Wyeth recalled formula in 2002...

You may also be interested in...

California WIC “Listening Sessions” Will Address Lipid-Enhanced Formulas

The "many changes in the formulation and marketing practices of infant formula in recent years" will be the subject of two upcoming "listening sessions" sponsored by the California Special Supplemental Nutrition Program for Women, Infants & Children

India To Scrap Intellectual Property Appellate Board

Legal experts explain why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.

Creating Healthcare Unicorns: Ex-Novartis CFO Shares Secret Sauce

Ex-Novartis executive and co-founder of investment bank MM Dillon & Co shares insights around where healthcare unicorns can be found and some core criteria to build such firms.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts